  See all
 |
Articles: Drug/Product Alerts |
Prior Articles
Sanofi Gets Green Light on Blockbuster Heart Treatment
PharmExec, 07/09/09
Japanese Ministry of Health approves Rasilez, a first-in-class direct renin inhibitor, for the treatment of high blood pressure
Novartis, 07/09/09
Free full text
European Medicines Agency (EMEA) Approves Cell Therapeutics, Inc.'s September Meeting Request to Discuss OPAXIO(TM) Marketing Authorization Application
Cell Therapeutics, 07/08/09
Free full text
Synthon First Generic Filer for Xyzal Oral Solution
Synthon, 07/08/09
Free full text
Mylan Receives FDA Approval for Generic Version of Prostate Cancer Treatment Casodex
Mylan, 07/08/09 Tolvaptan (Samsca): Vasopressin receptor antagonist approved for the treatment of clinically significant hypervolemic and euvolemic hyponatremia
Formulary, 07/07/09 European Commission approves statement on lipid improvement for Viramune label
Boehringer Ingelheim, 07/07/09
Free full text
KINAXO's Cellular Target Profiling reveals mTOR as a new target of Celebrex
b3c newswire, 07/07/09 Shire has filed a treatment protocol for velaglucerase alfa for Gaucher Disease
Shire, 07/07/09 Tadalafil (Adcirca): Phosphodiesterase type 5 inhibitor approved for the treatment of pulmonary arterial hypertension (WHO Group I)
Formulary, 07/06/09 Teva Announces Approval and Launch of Tri-Lo Sprintec Tablets
Teva Pharmaceutical Industries, 07/02/09
Free full text
Teva and Antares Announce FDA Approval of Needle-Free Injector Product for Administration of Tev-Tropin (Human Growth Hormone)
Teva Pharmaceutical Industries, 07/01/09
Free full text
Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder
Cephalon, 07/01/09
Free full text
FDA Grants LUCAS 2 Chest Compression System 510(k) Clearance in the United States
Medtronic, 06/30/09
Free full text
European Approval for UCB's Cimzia
PharmExec, 06/29/09 Approval of Partial Change of API Manufacturing Method and Pharmaceutical Formulation of the Recombinant Human Erythropoietin "Epogin Injection"
Chugai Pharmaceutical Co., 06/29/09
Free full text
Once-yearly Aclasta approved in EU to treat osteoporosis caused by steroid treatment in men and postmenopausal women
Novartis, 06/29/09
Free full text
Sandoz receives approval for first-ever Japanese biosimilar
Novartis, 06/26/09
Free full text
Maine legislature approves pharmacist immunization
American Pharmacists Association, 06/25/09
Free full text
Watson Pharmaceuticals Receives FDA Approval For Generic PLAN B(R)
Watson Pharmaceuticals, 06/25/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
143 Available Pages
|
|
